Application 208546

Type: ANDA
Sponsor: MSN

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	RIVAROXABAN	RIVAROXABAN	TABLET;ORAL	2.5MG	No	No
002	RIVAROXABAN	RIVAROXABAN	TABLET;ORAL	10MG	No	No
003	RIVAROXABAN	RIVAROXABAN	TABLET;ORAL	15MG	No	No
004	RIVAROXABAN	RIVAROXABAN	TABLET;ORAL	20MG	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A208546-001	RIVAROXABAN	RIVAROXABAN	2.5MG	TABLET / ORAL	AB	2025-10-24
A208546-002	RIVAROXABAN	RIVAROXABAN	10MG	TABLET / ORAL		2025-10-24
A208546-003	RIVAROXABAN	RIVAROXABAN	15MG	TABLET / ORAL		2025-10-24
A208546-004	RIVAROXABAN	RIVAROXABAN	20MG	TABLET / ORAL		2025-10-24

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A208546-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A208546-001	RIVAROXABAN	2.5MG	TABLET / ORAL	AB	2025-10-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A208546-002	RIVAROXABAN	10MG	TABLET / ORAL		2025-10-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A208546-003	RIVAROXABAN	15MG	TABLET / ORAL		2025-10-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A208546-004	RIVAROXABAN	20MG	TABLET / ORAL		2025-10-24	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A208546-001	RIVAROXABAN	2.5MG	TABLET / ORAL	AB	2025-10-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208546-002	RIVAROXABAN	10MG	TABLET / ORAL		2025-10-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208546-003	RIVAROXABAN	15MG	TABLET / ORAL		2025-10-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208546-004	RIVAROXABAN	20MG	TABLET / ORAL		2025-10-24	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208546-001	RIVAROXABAN	2.5MG	TABLET / ORAL	AB	2025-10-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208546-002	RIVAROXABAN	10MG	TABLET / ORAL		2025-10-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208546-003	RIVAROXABAN	15MG	TABLET / ORAL		2025-10-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208546-004	RIVAROXABAN	20MG	TABLET / ORAL		2025-10-24	`31067a03dcf5…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A208546-001	RIVAROXABAN	2.5MG	TABLET / ORAL	AB	2025-10-24	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A208546-002	RIVAROXABAN	10MG	TABLET / ORAL		2025-10-24	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A208546-003	RIVAROXABAN	15MG	TABLET / ORAL		2025-10-24	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A208546-004	RIVAROXABAN	20MG	TABLET / ORAL		2025-10-24	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A208546-001	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A208546-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208546-001	AB	1	`31067a03dcf5…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A208546-001	AB	1	`a50c72e98297…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Rivaroxaban	RIVAROXABAN	Novadoz Pharmaceuticals LLC	e8e4275c-6cbe-4976-8cae-f62baf954d27	2026-03-18	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208546 application number: ANDA208546